and will be important even beyond Alpha-1 antitrypsin deficiency." More information: Florian A. Rosenberger et al, Deep ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

As the field of proteomics continues to advance, scientists are using new methods to answer longstanding questions about rare ...

As part of an international study, researchers at the Max Planck Institute of Biochemistry used spatial proteomics method called Deep Visual Proteomics to analyze liver tissue from German and Danish ...

said that the U.S. FDA cleared the investigational new drug application for BEAM-302 for the treatment of alpha-1 antitrypsin deficiency (AATD), a genetic condition causing lung and liver disease.

AIRNA Raises Oversubscribed $155 Million Series B Financing to Fund Phase 1/2 Clinical Trial for Alpha-1 Antitrypsin Deficiency and ... results in lung and liver disease. AIR-001 precisely repairs ...

Studying a monogenic condition like Alpha-1 Antitrypsin Deficiency provides a unique opportunity to better understand disease progression. This work deepens our insight into protein folding disorders ...

In a nutshell: • Hereditary disease alpha-1-antitrypsin deficiency: researchers have discovered why some patients remain healthy despite a genetic defect, while others develop severe liver ...